Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Inactivated EV71 Vaccine (KMB-17) in Chinese Children
NCT01569581Phase 3Completed
- Sponsor
- Institute of Medical Biology
- Start
- Mar 2012
- Primary completion
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mumps vaccine, live (human diploid cell) in HIV-associated central nervous system involvement (HAND) (8 arms), sponsored by Institute of Medical Biology. Primary endpoints: Safety of Inactivated EV 71 Vaccine after first vaccination at 28 days, Safety of Inactivated EV 71 Vaccine after second vaccination at 28 days and 1 more. Started Mar 2012; status: completed.
02
Drugs
mumps vaccine, live (human diploid cell)
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT01569581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569581.